Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Zydus Lifesciences share price/ Zydus Lifesciences Profit Loss Annual
Zydus Lifesciences Profit & Loss Annual
Trade962.70 +14.00 (1.48%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 19,547.40 | 17,237.40 | 15,109.90 | 14,403.50 |
| Total Revenue | 19,547.40 | 17,237.40 | 15,109.90 | 14,403.50 |
| Costof Revenue Total | 6,228.20 | 7,056.30 | 6,248.50 | 5,442.70 |
| Gross Profit | 13,319.20 | 10,181.10 | 8,861.40 | 8,960.80 |
| Selling/ General/ Admin Expenses Total | 3,137.60 | 6,263.30 | 5,385.90 | 5,254.60 |
| Depreciation/ Amortization | 764.10 | 722.70 | 713.00 | 669.60 |
| Unusual Expense( Income) | 14.20 | 604.20 | -112.70 | 205.10 |
| Other Operating Expenses Total | 4,878.30 | 342.30 | 288.40 | 301.00 |
| Total Operating Expense | 15,022.40 | 14,988.80 | 12,523.10 | 11,873.00 |
| Operating Income | 4,525.00 | 2,248.60 | 2,586.80 | 2,530.50 |
| Interest Inc( Exp) Net- Non- Op Total | -2.00 | 3,210.00 | 2,554.00 | -1,217.00 |
| Other Net | 284.10 | -0.70 | -2.40 | -6.00 |
| Net Income Before Taxes | 4,808.90 | 2,589.70 | 2,838.10 | 2,399.20 |
| Provisionfor Income Taxes | 977.50 | 587.80 | 511.70 | 193.60 |
| Net Income After Taxes | 3,831.40 | 2,001.90 | 2,326.40 | 2,205.60 |
| Minority Interest | -113.30 | -131.60 | -131.00 | -51.40 |
| Equity In Affiliates | 1,184.00 | 946.00 | 462.00 | 474.00 |
| Net Income Before Extra Items | 3,836.50 | 1,964.90 | 2,241.60 | 2,201.60 |
| Total Extraordinary Items | 23.00 | -4.60 | 2,245.70 | -68.00 |
| Net Income | 3,859.50 | 1,960.30 | 4,487.30 | 2,133.60 |
| Income Availableto Com Excl Extra Ord | 3,836.50 | 1,964.90 | 2,241.60 | 2,201.60 |
| Income Availableto Com Incl Extra Ord | 3,859.50 | 1,960.30 | 4,487.30 | 2,133.60 |
| Diluted Net Income | 3,859.50 | 1,960.30 | 4,487.30 | 2,133.60 |
| Diluted Weighted Average Shares | 101.19 | 101.56 | 102.37 | 102.37 |
| Diluted EPS Excluding Extra Ord Items | 37.91 | 19.35 | 21.90 | 21.51 |
| Diluted Normalized EPS | 38.02 | 23.79 | 21.01 | 23.38 |
| Gain( Loss)on Saleof Assets | - | 208.00 | -17.00 | -36.00 |
| DPS- Common Stock Primary Issue | - | 6.00 | 2.50 | 3.50 |
*All figures in crores except per share values
Zydus Lifesciences Quick Links
Zydus Lifesciences Dividend Zydus Lifesciences Bonus Zydus Lifesciences News Zydus Lifesciences AGM Zydus Lifesciences Rights Zydus Lifesciences Splits Zydus Lifesciences Board Meetings Zydus Lifesciences Key Metrics Zydus Lifesciences Shareholdings Zydus Lifesciences Balance Sheet Zydus Lifesciences Cashflow Zydus Lifesciences Q1 Results Zydus Lifesciences Q2 Results Zydus Lifesciences Q3 Results Zydus Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)